BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18410893)

  • 1. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
    Fuji S; Kim SW; Fukuda T; Mori S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Heike Y; Tobinai K; Tanosaki R; Takaue Y
    Biol Blood Marrow Transplant; 2008 May; 14(5):510-7. PubMed ID: 18410893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.
    Rezvani AR; Storer BE; Storb RF; Mielcarek M; Maloney DG; Sandmaier BM; Martin PJ; McDonald GB
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1594-601. PubMed ID: 21806949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis.
    Akahoshi Y; Spyrou N; Hoepting M; Aguayo-Hiraldo P; Ayuk F; Chanswangphuwana C; Choe HK; Eder M; Etra AM; Grupp SA; Hexner EO; Hogan WJ; Kitko CL; Kraus S; Al Malki MM; Merli P; Qayed M; Reshef R; Schechter T; Ullrich E; Vasova I; Wölfl M; Zeiser R; Baez J; Beheshti R; Eng G; Gleich S; Kasikis S; Katsivelos N; Kowalyk S; Morales G; Young R; DeFilipp Z; Ferrara JLM; Levine JE; Nakamura R
    Blood Adv; 2024 Apr; 8(8):2047-2057. PubMed ID: 38324721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complication.
    Dai H; Penack O; Radujkovic A; Schult D; Majer-Lauterbach J; Blau IW; Bullinger L; Jiang S; Müller-Tidow C; Dreger P; Luft T
    Bone Marrow Transplant; 2021 Jul; 56(7):1573-1583. PubMed ID: 33517355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphiregulin as a biomarker for monitoring lifethreatening acute graft-
    Holtan SG; El Jurdi N; Rashidi A; Betts BC; Demorest C; Galvin JP; MacMillan ML; Weisdorf DJ; Panoskaltsis-Mortari A; Pratta MA
    Haematologica; 2024 May; 109(5):1557-1561. PubMed ID: 37706330
    [No Abstract]   [Full Text] [Related]  

  • 6. Differentiation of presumed sepsis from acute graft-versus-host disease by C-reactive protein and serum total IgE in bone marrow transplant recipients.
    Saarinen UM; Strandjord SE; Warkentin PI; Cheung NK; Lazarus HM; Coccia PF
    Transplantation; 1987 Oct; 44(4):540-6. PubMed ID: 3313843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Serum Alpha1-Antitrypsin Protease Inhibition before and after Clinical Hematopoietic Stem Cell Transplantation: Association with Risk for Non-Relapse Mortality.
    Brami I; Zuckerman T; Ram R; Avni B; Peretz G; Ostrovsky D; Lior Y; Faour C; McElvaney O; McElvaney NG; Lewis EC
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant Systemic Lipidomic Profiles in Allogeneic Stem Cell Transplant Recipients.
    Hatfield KJ; Bruserud Ø; Reikvam H
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-Reactive Protein Is an Independent Predictor of 30-Day Bacterial Infection Post-Liver Transplantation.
    Yu J; Shi X; Ma J; Chen R; Dong S; Lu S; Wu J; Yan C; Wu J; Zheng S; Li L; Xu X; Cao H
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Intelligent Clinical Decision Support System for Predicting Acute Graft-versus-host Disease (aGvHD) following Allogeneic Hematopoietic Stem Cell Transplantation.
    Salehnasab C; Hajifathali A; Asadi F; Parkhideh S; Kazemi A; Roshanpoor A; Mehdizadeh M; Tavakoli-Ardakani M; Roshandel E
    J Biomed Phys Eng; 2021 Jun; 11(3):345-356. PubMed ID: 34189123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STING and transplantation: can targeting this pathway improve outcomes?
    Bader CS; Jin L; Levy RB
    Blood; 2021 Apr; 137(14):1871-1878. PubMed ID: 33619537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined C-Reactive Protein and Novel Inflammatory Parameters as a Predictor in Cancer-What Can We Learn from the Hematological Experience?
    Bruserud Ø; Aarstad HH; Tvedt THA
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32707721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decision support tool to find the best cyclosporine dose when switching from intravenous to oral route in pediatric stem cell transplant patients.
    Leclerc V; Bleyzac N; Ceraulo A; Bertrand Y; Ducher M
    Eur J Clin Pharmacol; 2020 Oct; 76(10):1409-1416. PubMed ID: 32533216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant C-reactive protein as a prognostic marker in allogeneic stem cell transplantation: A PRISMA-compliant meta-analysis.
    Wu P; Liang W; Chen X; Chen L; Yang X; Yan Z; Wang W
    Medicine (Baltimore); 2019 Feb; 98(8):e14474. PubMed ID: 30813150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian Networks: A New Approach to Predict Therapeutic Range Achievement of Initial Cyclosporine Blood Concentration After Pediatric Hematopoietic Stem Cell Transplantation.
    Leclerc V; Ducher M; Bleyzac N
    Drugs R D; 2018 Mar; 18(1):67-75. PubMed ID: 29404858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of infectious complications after haploidentical hematopoietic stem cell transplantations.
    Atilla E; Atilla PA; Bozdağ SC; Demirer T
    Infection; 2017 Aug; 45(4):403-411. PubMed ID: 28417421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of pretransplant serum C-reactive protein in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
    Yamamoto W; Fujii E; Matsumoto K; Yamamoto E; Aoki J; Tanaka M; Ishigatsubo Y; Kanamori H
    Int J Hematol; 2016 Apr; 103(4):444-52. PubMed ID: 26791379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early post-transplant contrast-enhanced abdominopelvic CT scan predicts the risk of subsequent acute GvHD.
    Rashidi A; Lin MF; Cashen AF
    Bone Marrow Transplant; 2016 Jan; 51(1):150-2. PubMed ID: 26437071
    [No Abstract]   [Full Text] [Related]  

  • 19. MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.
    Sang W; Zhang C; Zhang D; Wang Y; Sun C; Niu M; Sun X; Zhou C; Zeng L; Pan B; Chen W; Yan D; Zhu F; Wu Q; Cao J; Zhao K; Chen C; Li Z; Li D; Loughran TP; Xu K
    Am J Hematol; 2015 Nov; 90(11):998-1007. PubMed ID: 26223969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host disease.
    Vaughn JE; Gooley T; Maziarz RT; Pulsipher MA; Bhatia S; Maloney DG; Sandmaier BM; Flowers ME; Storb R; Sorror ML
    Br J Haematol; 2015 Nov; 171(3):411-6. PubMed ID: 26194447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.